Name: ELTP Income Statement - Elite Pharmaceuticals Inc. /nv/ Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

ELTP - Elite Pharmaceuticals Inc. /nv/

USD | OTC Markets | Healthcare

ELTP Income Statement - Elite Pharmaceuticals Inc. /nv/ Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q4 FY 26	Q3 FY 26	Q2 FY 26	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17
Revenues
Revenues	40.7	31.6	36.3	40.2	32.0	14.4	18.9	18.8	17.9	15.5	14.2	9.0	8.6	9.3	8.6	7.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011
Revenues
Revenues	148.9	84.0	56.6	34.2	32.3	25.4	18.0	7.6	7.5	9.6	12.5	5.0	4.6	3.4	2.4	4.3
Cost of Revenue	73.8	44.0	30.3	17.6	17.5	13.5	10.0	4.7	3.5	5.9	4.5	3.0	3.2	2.3	1.0	2.7
Gross Profit	75.0	40.1	26.4	16.6	14.8	11.9	8.0	2.9	3.9	3.7	8.0	2.0	1.4	1.1	1.4	1.6
Operating Expenses
Research & Development	5.7	8.0	6.9	6.2	4.1	5.1	5.5	7.6	9.6	8.3	12.4	14.7	4.0	1.0	1.7
Operating Income
Operating Income	49.1	19.6	10.8	3.7	5.1	2.1	(2.3)	(9.2)	(9.1)	(7.4)	(8.3)	(16.5)	(5.3)	(1.6)
Non-Operating
Interest Income	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-
Tax & Net
Income Tax Expense	11.9	4.3	(19.6)	0.4	(1.7)	-	-	(0.7)	(1.0)	(1.9)	(0.5)	(0.0)	(0.3)	-	-
Per Share
EPS Basic	0.04	0.00	0.02	0.00	0.01	0.01	0.00	(0.01)	0.00	0.03	(0.01)	0.05	(0.21)	0.00	(0.06)	-
Supplementary Data
EBITDA	50.2	20.8	12.1	5.0	6.3	3.4	(1.0)	(7.9)	(8.1)	(6.6)	(7.7)	(15.9)	(4.8)	(1.1)	(1.5)	(0.4)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Tax & Net
Income Tax Expense	2.4	2.2	2.0	5.3	2.3	0.2	1.5	0.2	(1.3)	(0.8)	(17.7)	0.2	0.4	0.0	0.0	0.0	-	-	0.0	-	-	-	0.0	(0.9)	-	-	-	-	-	-	-	0.0	-	(1.1)	-	0.0	0.0	(1.9)	0.0	0.0
Net Income From Continuing Ops	18.5	18.6	13.7	(5.9)	17.0	(10.9)	(11.0)	0.6	3.3	0.7	14.9	1.1	(1.2)	3.0	1.5	0.3	2.4
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	18.5	18.6	13.7	(5.9)	17.0	(10.9)	(11.0)	0.6	3.3	0.7	14.9	1.1	(1.2)	3.0	1.5	0.3	2.4
Net Income Attributable To Parent	18.5	18.6	13.7	(5.9)	17.0	(10.9)	(11.0)	0.6	3.3	0.7	14.9	1.1	(1.2)	3.0	1.5	0.3
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	18.5	18.6	13.7	(5.9)	17.0	(10.9)	(11.0)	0.6	3.3	0.7	14.9	1.1	(1.2)	3.0	1.5

Operating Expenses
Research & Development	1.6	1.0	1.4	1.7	2.0	1.8	2.0	2.2	1.7	1.4	2.6	1.1	2.6	1.4	1.2	1.0	0.8	1.0	1.1	1.2	1.8	1.2	1.1	0.9	2.5	1.0	0.6	1.4	1.4	2.5	2.5	1.3	3.1	2.3	2.3	2.0	4.0	1.5	1.3	1.6
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	7.7	2.5	4.0	3.4	2.0	2.7	2.3	2.0	2.2	1.7	1.5	1.7	1.0	1.2	1.2	1.7	1.5
Depreciation & Amortization	0.3	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3
Amortization of Intangibles	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	10.6	3.9	5.9	5.5	6.1	5.0	4.7	4.6	4.4	3.5	4.5	3.1	4.2	3.0	2.7	3.0

Operating Income
Operating Income	10.2	9.0	8.2	21.7	11.2	1.1	3.5	3.9	3.7	3.5	1.9	1.6	(0.4)	2.0	1.1	1.0	0.9	1.8	1.4	1.0	(1.1)	1.0	1.3	0.8	(1.4)	0.7	(0.5)	(1.1)	(2.0)	(2.6)	(2.7)	(1.9)	(2.6)	(2.1)	(2.1)	(2.2)	(3.2)	(1.7)	(1.2)	(1.2)

Non-Operating
Interest Income	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Interest Expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.3	0.2	0.2	0.1	0.0
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	10.7	11.8	7.5	(22.3)	8.1	(11.8)	(13.0)	(3.0)	(1.7)	(3.6)	(4.7)	(0.3)	(0.5)	1.1	0.4	(0.7)	(0.2)
Pre-Tax Income	20.9	20.8	15.7	(0.6)	19.3	(10.7)	(9.5)	0.8	2.0	(0.1)	(2.7)	1.3	(0.9)	3.0	1.5	0.3	0.7

Supplementary Data
EBITDA	10.4	9.3	8.5	22.0	11.5	1.4	3.7	4.2	4.1	3.9	2.3	1.9	(0.0)	2.3	1.4	1.3	1.2	2.1	1.7	1.3	(0.7)	1.3	1.7	1.2	(1.0)	1.0	(0.1)	(0.8)	(1.7)	(2.3)	(2.3)	(1.6)	(2.2)	(1.8)	(1.9)	(2.1)	(2.7)	(1.7)	(1.2)	(1.1)
EBIT	10.2	9.0	8.2	21.7	11.2	1.1	3.5	3.9	3.7	3.5	1.9	1.6	(0.4)	2.0	1.1	1.0	0.9	1.8	1.4